{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:04:28Z","timestamp":1788383068131,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.clim.2018.07.005","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:57:04Z","timestamp":1531270624000},"page":"80-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["HLA-G protein expression in colorectal cancer evaluated by immunohistochemistry and western blot analysis: Its expression characteristics remain enigmatic"],"prefix":"10.1016","volume":"194","author":[{"given":"Marloes","family":"Swets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6101-7146","authenticated-orcid":false,"given":"Dani\u00eblle","family":"Krijgsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald L.P.","family":"van Vlierberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7717-7416","authenticated-orcid":false,"given":"Arnoud","family":"Boot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap D.","family":"van Eendenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5773-7730","authenticated-orcid":false,"given":"Tom","family":"van Wezel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Gelderblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis J.H.","family":"van de Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"van den Elsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.K.","family":"Kuppen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clim.2018.07.005_bb0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.clim.2018.07.005_bb0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.clim.2018.07.005_bb0015","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s00262-004-0517-9","article-title":"The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape","volume":"53","author":"Algarra","year":"2004","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.clim.2018.07.005_bb0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijc.11681","article-title":"MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma","volume":"109","author":"Atkins","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.clim.2018.07.005_bb0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ijc.2910370203","article-title":"Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer","volume":"37","author":"Momburg","year":"1986","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.clim.2018.07.005_bb0030","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.semcancer.2007.07.005","article-title":"Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?","volume":"17","author":"Wischhusen","year":"2007","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.clim.2018.07.005_bb0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fimmu.2011.00048","article-title":"Expression regulation of major histocompatibility complex class I and class II encoding genes","volume":"Vol. 2","author":"van den Elsen","year":"2011","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2018.07.005_bb0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1476-4598-12-43","article-title":"The microRNA-148\/152 family: multi-faceted players","volume":"12","author":"Chen","year":"2013","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.clim.2018.07.005_bb0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tig.2008.07.004","article-title":"MicroRNA target site polymorphisms and human disease","volume":"24","author":"Sethupathy","year":"2008","journal-title":"Trends Genet."},{"issue":"2","key":"10.1016\/j.clim.2018.07.005_bb0050","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4049\/jimmunol.144.2.731","article-title":"Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule","volume":"144","author":"Ellis","year":"1990","journal-title":"J. Immunol."},{"issue":"4952","key":"10.1016\/j.clim.2018.07.005_bb0055","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1126\/science.2326636","article-title":"A class I antigen, HLA-G, expressed in human trophoblasts","volume":"248","author":"Kovats","year":"1990","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.clim.2018.07.005_bb0060","doi-asserted-by":"crossref","first-page":"11520","DOI":"10.1073\/pnas.94.21.11520","article-title":"Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis","volume":"94","author":"Rouas-Freiss","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.clim.2018.07.005_bb0065","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/molehr\/gah185","article-title":"The soluble pool of HLA-G produced by human trophoblasts does not include detectable levels of the intron 4-containing HLA-G5 and HLA-G6 isoforms","volume":"11","author":"Blaschitz","year":"2005","journal-title":"Mol. Hum. Reprod."},{"issue":"2","key":"10.1016\/j.clim.2018.07.005_bb0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1399-0039.1997.tb02852.x","article-title":"Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody","volume":"50","author":"Loke","year":"1997","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.clim.2018.07.005_bb0075","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.it.2017.01.009","article-title":"HLA-G: at the Interface of maternal-fetal tolerance","volume":"38","author":"Ferreira","year":"2017","journal-title":"Trends Immunol."},{"issue":"12","key":"10.1016\/j.clim.2018.07.005_bb0080","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.4049\/jimmunol.1002629","article-title":"HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients","volume":"185","author":"de Kruijf","year":"2010","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.clim.2018.07.005_bb0085","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1073\/pnas.95.8.4510","article-title":"HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance","volume":"95","author":"Paul","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.clim.2018.07.005_bb0090","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.semcancer.2007.07.003","article-title":"Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses","volume":"17","author":"Rouas-Freiss","year":"2007","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.clim.2018.07.005_bb0095","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1186\/1471-2407-14-486","article-title":"Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study","volume":"14","author":"Reimers","year":"2014","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.clim.2018.07.005_bb0100","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00018-010-0583-4","article-title":"Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?","volume":"68","author":"Amiot","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.clim.2018.07.005_bb0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.ai.2015.04.001","article-title":"HLA-G: An immune checkpoint molecule","volume":"127","author":"Carosella","year":"2015","journal-title":"Adv. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2018.07.005_bb0110","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/bjc.2013.696","article-title":"Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients","volume":"110","author":"Zeestraten","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.clim.2018.07.005_bb0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cellimm.2014.10.003","article-title":"Predictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients","volume":"293","author":"Guo","year":"2015","journal-title":"Cell. Immunol."},{"issue":"11","key":"10.1016\/j.clim.2018.07.005_bb0120","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/ijc.30667","article-title":"Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages","volume":"140","author":"Kirana","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.clim.2018.07.005_bb0125","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.it.2008.02.012","article-title":"A critical look at HLA-G","volume":"29","author":"Apps","year":"2008","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.clim.2018.07.005_bb0130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.humimm.2003.10.005","article-title":"The 4H84 monoclonal antibody detecting beta2m free nonclassical HLA-G molecules also binds to free heavy chains of classical HLA class I antigens present on activated lymphocytes","volume":"65","author":"Polakova","year":"2004","journal-title":"Hum. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2018.07.005_bb0135","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.humimm.2016.03.001","article-title":"HLA-G and classical HLA class I expression in primary colorectal cancer and associated liver metastases","volume":"77","author":"Swets","year":"2016","journal-title":"Hum. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2018.07.005_bb0140","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.humimm.2016.05.023","article-title":"Promoter methylation and mRNA expression of HLA-G in relation to HLA-G protein expression in colorectal cancer","volume":"77","author":"Swets","year":"2016","journal-title":"Hum. Immunol."},{"issue":"5","key":"10.1016\/j.clim.2018.07.005_bb0145","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.humimm.2005.01.007","article-title":"The single antigen expressing lines (SALs) concept: an excellent tool for screening for HLA-specific antibodies","volume":"66","author":"Zoet","year":"2005","journal-title":"Hum. Immunol."},{"issue":"12","key":"10.1016\/j.clim.2018.07.005_bb0150","doi-asserted-by":"crossref","first-page":"14499","DOI":"10.18632\/oncotarget.7391","article-title":"Characterization of novel low passage primary and metastatic colorectal cancer cell lines","volume":"7","author":"Boot","year":"2016","journal-title":"Oncotarget"},{"issue":"13","key":"10.1016\/j.clim.2018.07.005_bb0155","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0161-5890(98)00077-7","article-title":"The monoclonal antibody HCA2 recognises a broadly shared epitope on selected classical as well as several non-classical HLA class I molecules","volume":"35","author":"Seitz","year":"1998","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.clim.2018.07.005_bb0160","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0161-5890(98)00026-1","article-title":"Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents","volume":"35","author":"Sernee","year":"1998","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2018.07.005_bb0165","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<512::AID-IJC2>3.0.CO;2-O","article-title":"Expression of HLA G in human tumors is not a frequent event","volume":"81","author":"Real","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.clim.2018.07.005_bb0170","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1399-0039.2012.01922.x","article-title":"Reassessment of HLA-G isoform specificity of MEM-G\/9 and 4H84 monoclonal antibodies","volume":"80","author":"Zhao","year":"2012","journal-title":"Tissue Antigens"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161730774X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161730774X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T16:58:39Z","timestamp":1693760319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166161730774X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":34,"alternative-id":["S152166161730774X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2018.07.005","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-G protein expression in colorectal cancer evaluated by immunohistochemistry and western blot analysis: Its expression characteristics remain enigmatic","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2018.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}